DK1294400T3 - Vaccine mod mund- og klovsyge - Google Patents

Vaccine mod mund- og klovsyge

Info

Publication number
DK1294400T3
DK1294400T3 DK01949547.2T DK01949547T DK1294400T3 DK 1294400 T3 DK1294400 T3 DK 1294400T3 DK 01949547 T DK01949547 T DK 01949547T DK 1294400 T3 DK1294400 T3 DK 1294400T3
Authority
DK
Denmark
Prior art keywords
foot
vaccine against
mouth disease
against foot
mouth
Prior art date
Application number
DK01949547.2T
Other languages
English (en)
Inventor
Andrew King
Alison Burman
Michel Lombard
Jean-Christophe Audonnet
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of DK1294400T3 publication Critical patent/DK1294400T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK01949547.2T 2000-06-29 2001-06-27 Vaccine mod mund- og klovsyge DK1294400T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008437A FR2810888B1 (fr) 2000-06-29 2000-06-29 Vaccin contre la fievre aphteuse
PCT/FR2001/002042 WO2002000251A1 (fr) 2000-06-29 2001-06-27 Vaccin contre la fievre aphteuse

Publications (1)

Publication Number Publication Date
DK1294400T3 true DK1294400T3 (da) 2012-07-23

Family

ID=8851899

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01949547.2T DK1294400T3 (da) 2000-06-29 2001-06-27 Vaccine mod mund- og klovsyge

Country Status (13)

Country Link
US (1) US7531182B2 (da)
EP (1) EP1294400B1 (da)
JP (1) JP5153984B2 (da)
CN (1) CN1440296B (da)
AT (1) ATE552845T1 (da)
AU (1) AU2001270678A1 (da)
BR (1) BR0112071B1 (da)
CY (1) CY1116491T1 (da)
DK (1) DK1294400T3 (da)
ES (1) ES2386373T3 (da)
FR (1) FR2810888B1 (da)
PT (1) PT1294400E (da)
WO (1) WO2002000251A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1550453B1 (en) * 2002-09-12 2015-05-27 International Institute of Cancer Immunology, Inc. Cancer antigen peptide preparation
CN1320116C (zh) * 2002-10-18 2007-06-06 中国人民解放军军需大学军事兽医研究所 O型口蹄疫病毒o_ny00株基因组序列
CN100381170C (zh) * 2003-09-03 2008-04-16 上海华谊生物技术有限公司 一种口蹄疫双价多肽疫苗及其制备方法和用途
CN1290579C (zh) * 2003-10-15 2006-12-20 北京迪威华宇生物技术有限公司 重组口蹄疫病毒vp1融合蛋白疫苗
CN100342911C (zh) * 2004-01-13 2007-10-17 厦门大学 A、o型口蹄疫病毒双价dna疫苗及其制备方法
US7527960B2 (en) * 2004-06-25 2009-05-05 Merial Limited Avipox recombinants expressing foot and mouth disease virus genes
CA2592366C (en) 2004-12-14 2013-11-19 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Recombinant foot and mouth disease vaccine
US9717788B2 (en) 2007-03-02 2017-08-01 Glaxosmithkline Biologicals Sa Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
RU2631129C1 (ru) * 2007-05-21 2017-09-19 Федеральное Казенное Предприятие "Щелковский Биокомбинат" Способ изготовления вакцины против ящура и вакцина против ящура
CL2008001806A1 (es) * 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
CN101270155B (zh) * 2008-05-06 2011-04-27 中国农业科学院兰州兽医研究所 通过耐酸性改造在昆虫中组装口蹄疫病毒空衣壳的方法
GB0918375D0 (en) 2009-10-20 2009-12-02 Animal Health Inst Construct
JP5934101B2 (ja) * 2009-10-30 2016-06-15 アグリサーチ リミテッド 修飾された中性脂質を被包するタンパク質及びその使用
US8974834B2 (en) 2010-01-15 2015-03-10 Ecolab Usa Inc. Method for producing reservoir layer for hoof treatment and reservoir layer
WO2011112945A2 (en) * 2010-03-12 2011-09-15 Merial Limited Foot and mouth disease virus recombinant vaccines and uses thereof
US8765141B2 (en) * 2010-07-01 2014-07-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
CN101948811B (zh) * 2010-08-18 2013-01-09 中国农业科学院兰州兽医研究所 用反向遗传操作拓展口蹄疫疫苗株抗原谱及疫苗制备方法
GB201014965D0 (en) * 2010-09-08 2010-10-20 Animal Health Inst Vaccine
US8906384B2 (en) * 2010-12-22 2014-12-09 The United States Of America As Represented By The Secretary Of Agriculture Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
CN103060278B (zh) * 2012-10-23 2014-07-09 于力 亚洲1型口蹄疫病毒耐酸突变株、其携带的衣壳蛋白及其编码基因和应用
RU2522868C1 (ru) * 2013-03-06 2014-07-20 Федеральное государственное унитарное предприятие "Щелковский биокомбинат" Способ изготовления вакцины против ящура
WO2014145951A2 (en) 2013-03-15 2014-09-18 The Trustees Of The University Of Pennsylvania Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
BR112015024391A2 (pt) * 2013-03-26 2017-10-24 The Pirbright Inst mutante de proteína, capsídeo, método para melhorar a estabilidade de um capsídeo, molécula de ácido nucleico isolada, célula hospedeira, micro-organismo recombinante carreador vivo, vacina, uso de um mutante da proteína vp2, e, métodos para preparar uma vacina e um mutante da proteína
KR101629353B1 (ko) * 2013-06-20 2016-06-15 대한민국 구제역 a형 표준 백신주의 방어항원이 발현되는 재조합 구제역 바이러스 및 그의 제조방법
KR101629282B1 (ko) * 2013-06-26 2016-06-15 대한민국 구제역 아시아1 혈청형 유전형 v 바이러스의 방어항원이 발현되는 재조합 구제역 바이러스 및 그의 제조방법
KR101629345B1 (ko) * 2013-06-26 2016-06-15 대한민국 구제역 아시아1 혈청형 유전형 iv 바이러스의 방어항원이 발현되는 재조합 구제역 바이러스 및 그의 제조방법
KR101578425B1 (ko) 2013-07-26 2015-12-18 대한민국 구제역 sat1형 wz 지역형의 방어항원이 발현되는 재조합 바이러스 및 그의 제조방법
RU2562547C1 (ru) * 2014-04-16 2015-09-10 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Вакцина инактивированная сорбированная против ящура типа а
US10010605B2 (en) * 2014-09-23 2018-07-03 Merial, Inc. FMDV recombinant vaccines and uses thereof
AR102547A1 (es) 2014-11-07 2017-03-08 Takeda Vaccines Inc Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
CN105505853B (zh) * 2015-12-23 2019-03-15 中农威特生物科技股份有限公司 一种用于bhk-21细胞高密度悬浮培养的低血清培养基及其在口蹄疫病毒增殖中的应用
TWI760322B (zh) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
RU2617043C1 (ru) * 2016-03-24 2017-04-19 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" (ФГБНУ ВНИТИБП) Вакцина против ящура и способ её получения и применения
EP3675902A4 (en) 2017-08-28 2021-06-23 Board of Trustees of Michigan State University COMPOSITIONS AND METHODS OF TREATMENT OF CANCER AND INFECTION USING BACTERIOPHAGE AND THEIR MUTANTS
CN111744000B (zh) * 2020-07-14 2021-03-23 中国农业科学院兰州兽医研究所 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用
CN113817068B (zh) * 2020-12-24 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的o型口蹄疫疫苗
CN114957480B (zh) * 2021-02-23 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的a型口蹄疫疫苗
IL310903A (en) 2021-08-20 2024-04-01 Intervet Int Bv Method of producing a foot and mouth disease virus virus-like particle
EP4387661A1 (en) 2021-08-20 2024-06-26 Intervet International B.V. Method of producing a foot and mouth disease virus virus-like particle
IL310908A (en) 2021-08-20 2024-04-01 Intervet Int Bv A virus-like FMDV particle with a stabilizing mutation
EP4387665A1 (en) 2021-08-20 2024-06-26 The Pirbright Institute Fmdv virus-like particle with double stabilizing mutation
KR102952051B1 (ko) * 2022-10-19 2026-04-14 (주) 셀엔백스 구제역 바이러스 O형 캡시드 단백질 유래 단백질 및 sFc 단백질을 포함하는 재조합 단백질 및 이의 용도
WO2026162741A1 (en) 2025-02-01 2026-08-06 The Pirbright Institute Fmdv virus-like particle with stabilizing mutations
WO2026162747A1 (en) 2025-02-01 2026-08-06 The Chancellor, Masters And Scholars Of The University Of Oxford Fmdv virus-like particle with stabilizing mutations
WO2026162693A1 (en) 2025-02-01 2026-08-06 Intervet International B.V. A method to preserve virus like particles of foot and mouth disease virus
WO2026162694A1 (en) 2025-02-01 2026-08-06 The Chancellor, Masters And Scholars Of The University Of Oxford Fmdv virus-like particle with stabilizing mutations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
MX9304089A (es) * 1992-07-08 1994-01-31 Schering Corp Uso de gm-csf como una vacuna adyuvante.
JPH11504631A (ja) 1995-04-25 1999-04-27 バイカル インコーポレイテッド Ｄｎａ／脂質複合体の単一バイアル製剤
DE19638044A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren

Also Published As

Publication number Publication date
CY1116491T1 (el) 2017-03-15
PT1294400E (pt) 2012-07-10
US7531182B2 (en) 2009-05-12
ATE552845T1 (de) 2012-04-15
US20040001864A1 (en) 2004-01-01
CN1440296A (zh) 2003-09-03
JP5153984B2 (ja) 2013-02-27
CN1440296B (zh) 2012-04-11
WO2002000251A9 (fr) 2002-04-04
JP2004501874A (ja) 2004-01-22
FR2810888B1 (fr) 2004-07-30
EP1294400B1 (fr) 2012-04-11
FR2810888A1 (fr) 2002-01-04
WO2002000251A1 (fr) 2002-01-03
ES2386373T3 (es) 2012-08-20
BR0112071B1 (pt) 2014-08-26
AU2001270678A1 (en) 2002-01-08
EP1294400A1 (fr) 2003-03-26
BR0112071A (pt) 2003-05-20

Similar Documents

Publication Publication Date Title
BR0112071A (pt) Vacina contra a febre aftosa
Beard et al. Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus
NO2013003I2 (no) Forbindelser som NS3-serinproteaseinhibitorer for hepatitt C-virus, farmasøytiske preparater og anvendelse av forbindelsene til fremstilling av et medikament
WO2003048184A3 (en) Flavivirus ns1 subunit vaccine
UA85536C2 (en) Viral antigens
ATE526411T1 (de) Avirulente, immunogene flavivirus-chimäre
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
AR022510A1 (es) Formulaciones de vacunas contra el papilomavirus humano
CL2004002017A1 (es) Forma de dosificacion termoformada a prueba de abuso que contiene (a) uno o mas principios activos susceptibles de abuso, (b) opcionalmente sustancias auxiliares, (c) al menos un polimero sintetico o natural de un grupo definido y (d) opcionalmente a
BRPI9911870B8 (pt) vacina de parvovírus e circovírus de suíno
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
JP2013507948A5 (da)
BG106417A (en) Vaccine
AR038143A1 (es) Agonistas del receptor 2 del factor liberador de la corticotropina
RU2009145104A (ru) Флавивирус с двухкомпонентным геномом и его использование
DK0652957T3 (da) Samlede viruspartikler og deres anvendelse i en vaccine imod rotaviral sygdom
WO2002024897A3 (en) Conditionally replicating viral vectors and their use
WO2002078631A3 (en) Improved conditionally replicating vectors for inhibiting viral infections
MXPA03009763A (es) Vacuna contra el virus de la enfermedad de la fiebre aftosa.
NZ516725A (en) Use of modified HPV as a carrier for vaccine against cancer or viral infection of human papillomavirus
MXPA01005808A (es) Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.
ATE408013T1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
TW200509964A (en) VP1 of foot-and-mouth disease virus
FR2837104B1 (fr) Utilisation de melange de lipopeptides pour la fabrication de vaccins
CA2363493A1 (en) Attenuated forms of bovine viral diarrhea virus